Correlation Between Aarey Drugs and Patanjali Foods

Can any of the company-specific risk be diversified away by investing in both Aarey Drugs and Patanjali Foods at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Aarey Drugs and Patanjali Foods into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Aarey Drugs Pharmaceuticals and Patanjali Foods Limited, you can compare the effects of market volatilities on Aarey Drugs and Patanjali Foods and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Aarey Drugs with a short position of Patanjali Foods. Check out your portfolio center. Please also check ongoing floating volatility patterns of Aarey Drugs and Patanjali Foods.

Diversification Opportunities for Aarey Drugs and Patanjali Foods

0.46

Correlation Coefficient

Aarey Drugs  Patanjali Foods

Very weak diversification

The 3 months correlation between Aarey and Patanjali is 0.46. Overlapping area represents the amount of risk that can be diversified away by holding Aarey Drugs Pharmaceuticals and Patanjali Foods Limited in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Patanjali Foods and Aarey Drugs is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Aarey Drugs Pharmaceuticals are associated (or correlated) with Patanjali Foods. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Patanjali Foods has no effect on the direction of Aarey Drugs i.e., Aarey Drugs and Patanjali Foods go up and down completely randomly.

Pair Corralation between Aarey Drugs and Patanjali Foods

Assuming the 90 days trading horizon Aarey Drugs Pharmaceuticals is expected to under-perform the Patanjali Foods. In addition to that, Aarey Drugs is 2.35 times more volatile than Patanjali Foods Limited. It trades about -0.27 of its total potential returns per unit of risk. Patanjali Foods Limited is currently generating about 0.03 per unit of volatility. If you would invest  177,380  in Patanjali Foods Limited on December 29, 2024 and sell it today you would earn a total of  3,460  from holding Patanjali Foods Limited or generate 1.95% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Aarey Drugs Pharmaceuticals  vs.  Patanjali Foods Limited

Aarey Drugs Pharmace

Risk-Adjusted Performance

Very Weak

Over the last 90 days Aarey Drugs Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Even with uncertain performance in the last few months, the Stock's basic indicators remain relatively invariable which may send shares a bit higher in April 2025. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.

Patanjali Foods

Risk-Adjusted Performance

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Patanjali Foods Limited are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Despite somewhat strong basic indicators, Patanjali Foods is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors.

Pair Trading with Aarey Drugs and Patanjali Foods

The main advantage of trading using opposite Aarey Drugs and Patanjali Foods positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Aarey Drugs position performs unexpectedly, Patanjali Foods can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Patanjali Foods will offset losses from the drop in Patanjali Foods' long position.

The idea behind Aarey Drugs Pharmaceuticals and Patanjali Foods Limited pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.